Tag Archives: professor

Study links cardiac hormone-related inflammatory pathway with tumor growth

The research may lead to the development of new drugs or delivery systems to treat cancer by blocking this receptor, known as natriuretic peptide receptor A (NPRA). The findings appeared online recently in the journal Stem Cells. "Our results show that NRPA signaling by cancer cells produces some molecular factors that attract stem cells, which in turn form blood vessels that provide oxygen and nutrients to the tumor," said the study’s principal investigator Subhra Mohapatra, PhD, associate professor in the Department of Molecular Medicine…

Protein in blood exerts natural anti-cancer protection

The study, published June 24 online in the Proceedings of the National Academy of Sciences, suggests it may be possible to harness the power of this naturally occurring anticancer agent as a way to treat cancer, including metastases. In several different publications it has been described the ability of decorin to affect a number of biological processes including inflammatory responses, wound healing, and angiogenesis. In this new article, the study’s senior investigator, Renato Iozzo, M.D., Ph.D., has labeled decorin a "soluble tumor repressor" — the first to be found that specifically targets new blood vessels, which are pushed to grow by the cancer, and forces the vessel cells to "eat" their internal components. …

Surgeons report melanoma recurs after 10 years in more than 6 percent of patients

"For patients with melanoma, survival beyond 10 years without a recurrence has been considered nearly synonymous with a cure," said principal investigator Mark Faries, MD, FACS, a professor of surgery at the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA. "However, most studies do not follow up patients longer than 10 years. Our study found that late melanoma recurrence is not rare and that it occurs more frequently in certain patient groups." Patients with a higher chance of melanoma — the deadliest form of skin cancer — recurring more than a decade later, compared with early recurrence of melanoma within the first three years, were typically a younger age at initial diagnosis and generally exhibited less serious characteristics of the original tumor, Dr. Faries and colleagues reported…

Protein is involved with colon cancer cell’s ability to invade other cells

Previous research shows that km23-1 is involved in the movement of cancer cells and in the control of specific proteins at the leading edge of moving cells. Kathleen Mulder, professor of biochemistry and molecular biology, who discovered the protein, now says km23-1 is used in the cancer cell’s ability to move out of a tumor in the early stages ofinvasion. "km23-1 may be able to help in this process due to its role in the assembly of large groups of proteins favorable to cancer invasion," Mulder said. Colorectal cancer is the third most common cancer in the United States. …

Study details cancer-promoting mechanisms of overlooked components in secondhand smoke

A University of Colorado Cancer Center study published in the journal PLoS One explores two of these low-molecular-weight (LMW) PAHs — 1-methylanthracene (1-MeA) and 2-methylanthracene (2-MeA) — and shows that while they don’t necessarily cause cancer, 1-MeA promotes conditions that will likely allow cancer to grow. "There’s a big distinction between initiating cancer and promoting it," says Alison Bauer, PhD, CU Cancer Center investigator and assistant professor at the Colorado School of Public Health. Her study showed that in a mouse cell model using a progenitor cell of lung cancer, the LMW 1-MeA promoted inflammation and increased mitogenic pathways, both of which are linked to tumor promotion. 2-MeA, while nearly structurally identical, did not…